Conversion of carbon dioxide (CO2) with the
help of
an appropriate electrocatalyst with high stability, low onset potential,
and exceptional selectivity is still one of the great tasks in the
electrocatalytic reduction of CO2 to valuable chemicals.
Herein, by means of systematic first-principles simulations, we investigate
the CO2 reduction reaction (CO2RR) activity
of zirconium-based single-, double-, and triple-atom (Zr
n
@C2N; n = 1–3)
catalysts anchored on a graphitic carbon-nitride monolayer. In tune
with the Sabatier principle, our results reveal that a moderate CO2 binding is vital for a low onset potential for the CO2RR. Consequently, based on rigorous free energy calculations,
the Zr-based single-atom catalyst (SAC) is found to be most effective
to convert CO2 to valuable products such as HCOOH and CH3OH. It is worth noting that CO2 reduction to HCOOH
is spontaneous via the *HCOO intermediate on Zr1@C2N and involves a low onset potential of −0.23 V with
respect to the reversible hydrogen electrode from the *COOH intermediate.
Among all the catalysts evaluated computationally, the Zr SAC further
reveals the lowest onset potential of −0.89 V for CH3OH formation. The results show that the Zr-based catalysts especially
Zr1@C2N are found to effectively suppress the
competitive hydrogen evolution reaction and promote the CO2RR. Moreover, all three catalysts exhibit high kinetic and thermal
stability with negligible distortion due to which their structures
can be retained very well up to 600 K. Thus, the current work may
provide effective catalyst-design strategies for enhancing the electrocatalytic
CO2RR performance of Zr-based materials.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.